Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: A Japanese cohort

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 7, 2013, Pages 1247-1251

  Ohara, Hirotaka ^a   Nakazawa, Takahiro ^a   Kawa, Shigeyuki ^c   Kamisawa, Terumi ^f   Shimosegawa, Tooru ⁱ   Uchida, Kazushige ^j   Hirano, Kenji ^g   Nishino, Takayoshi ^h   Hamano, Hideaki ^d   Kanno, Atsushi ⁱ   Notohara, Kenji ^k   Hasebe, Osamu ^b   Muraki, Takashi ^e   Ishida, Etsuji ^k   Naitoh, Itaru ^a   Okazaki, Kazuichi ^j  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagano Municipal Hospital   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

^d SHINSHU UNIVERSITY HOSPITAL   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

ⁱ TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j KANSAI MEDICAL UNIVERSITY   (Japan)

^k KURASHIKI CENTRAL HOSPITAL   (Japan)

more..

Author keywords

Autoimmune pancreatitis; IgG4 related sclerosing cholangitis; IgG4 SC; Primary sclerosing cholangitis

Indexed keywords

IMMUNOGLOBULIN G4;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMON BILE DUCT STENOSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTRAHEPATIC BILE DUCT; JAPANESE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY;

EID: 84879453640     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12248     Document Type: Article

References (23)

1. Umehara H, Okazaki K, Masaki Y etal. Comprehensive diagnostic criteria for IgG4-related disease (IgG4RD), 2011. Mod. Rheumatol. 2012; 22: 21-30.
2. Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J. Gastroenterol. 2011; 46: 277-288.
3. Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat. Sci. 2012; 19: 536-542.
4. Nakazawa T, Ohara H, Sano H etal. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 2005; 30: 20-25.
5. Nishino T, Toki F, Oyama H etal. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005; 30: 76-82.
6. Nakazawa T, Ando T, Hayashi K etal. Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholanigiographic classification. J. Gastroenterol. 2012; 40: 79-87.
7. Hamano H, Kawa S, Uehara T etal. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest. Endosc. 2005; 62: 152-157.
8. Hamano H, Kawa S, Horiuchi A etal. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 2001; 344: 732-738.
9. Shimosegawa T, Chari ST, Frulloni L etal. International consensus diagnostic criteria for autoimmune pancreatitis. Pancreas 2011; 40: 352-358.
10. Oseini AM, Chaiteerakij R, Shire AM etal. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011; 54: 940-948.
11. Nakazawa T, Ohara H, Sano H etal. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest. Endosc. 2004; 60: 937-944.
12. The Japan Pancreatic Society and Research Committee of Intractable Diseases of the Pancreas. Clinical diagnostic criteria for autoimmune pancreatitis 2011. J. Jpn. Pancreas Soc. 2012; 27: 17-25. (in Japanese).
13. Lindor KD, LaRusso NF. Primary sclerosing cholangitis. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Disease of the Liver, 9th edn. Philadelpia: JB Lippincott, 2003; 673-684.
14. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 2006; 32: 229.
15. Ohara H, Nakazawa T, Sano H etal. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005; 31: 232-237.
16. Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J. Gastroenterol. 2006; 41: 1197-1205.
17. Naitoh I, Nakazawa T, Ohara H etal. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis. Pancreas 2010; 39: e1-5.
18. Kamisawa T, Funata N, Hayashi Y etal. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 2003; 38: 982-984.
19. Koyabu M, Uchida K, Miyoshi H etal. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J. Gastroenterol. 2010; 45: 732-741.
20. Naitoh I, Nakazawa T, Ohara H etal. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J. Gastroenterol. 2009; 44: 1147-1155.
21. Ghazale A, Chari ST, Zhang L etal. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134: 706-715.
22. Nakazawa T, Ohara H, Sano H etal. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest. Endosc. 2007; 65: 99-108.
23. Naitoh I, Nakazawa T, Ohara H etal. Comparative evaluation of the Japanese diagnostic criteria for autoimmune pancreatitis. Pancreas 2010; 39: 1173-1179.